Aclaris Therapeutics ACRS
NASDAQ ACRS
$5.26 -0.02 (-0.28%)
As of: Sep 30, 2026 · 1:12 PM EDT

Aclaris Therapeutics, Inc. (ACRS) FCF Margin (2017 - 2026)

Updated

Aclaris Therapeutics' FCF Margin came in at -1221.92% for Q2 2026, down 658.38 percentage points from -563.53% a year earlier and down 312.00 percentage points from the prior quarter.

Analysis

Aclaris Therapeutics, Inc. (ACRS) FCF Margin (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported FCF Margin of -756.50%, down 696.63 percentage points year-over-year; for FY2025, it was -603.42%, down 495.54 percentage points from FY2024.

  • FCF Margin carries a five-year change of -0.43 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -107.88% in FY2024 (+146.95 pp), -254.84% in FY2023 (-25.70 pp), -229.13% in FY2022 (+546.52 pp) and -775.65% in FY2021 (-172.66 pp).
  • The Q2 2026 figure represents the lowest quarterly FCF Margin since Q2 2022.
  • Year-over-year, FCF Margin has declined for seven consecutive quarters, with an average year-over-year change of -231.83 percentage points over the last eight quarters.
  • The fastest year-over-year change in FCF Margin over five years came in Q4 2022 (a gain of 903.00 percentage points), and the weakest in Q4 2025 (a drop of 918.79 percentage points).
  • Business Quant data shows ACRS's FCF Margin at -909.92% (Q1 2026), -1015.83% (Q4 2025) and -332.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,221.92%
Mar 31, 2026 -909.92%
Dec 31, 2025 -1,015.83%
Sep 30, 2025 -332.07%
Jun 30, 2025 -563.53%
Mar 31, 2025 -900.34%
Dec 31, 2024 -97.04%
Sep 30, 2024 506.21%
Jun 30, 2024 -444.97%
Mar 31, 2024 -873.64%
Dec 31, 2023 -40.99%
Sep 30, 2023 -265.47%
Jun 30, 2023 -1,117.44%
Mar 31, 2023 -1,064.32%
Dec 31, 2022 -247.90%
Sep 30, 2022 -41.89%
Jun 30, 2022 -1,299.21%
Mar 31, 2022 -1,454.44%
Dec 31, 2021 -1,150.90%
Sep 30, 2021 -642.68%
API Access

Aclaris Therapeutics, Inc. FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY